Cardiovascular risk factors among people with severe mental illness in Italy: A cross-sectional comparative study

General Hospital Psychiatry

Volumn 36, Issue 6, 2014, Pages 698-702

  Clerici, Massimo ^a   Bartoli, Francesco ^a   Carretta, Daniele ^a   Crocamo, Cristina ^a   Bebbington, Paul ^b   Carrà, Giuseppe ^b  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Cardiovascular diseases; Comorbidity; Mediterranean diet; Mental Disorders; Risk factors

Indexed keywords

ARIPIPRAZOLE; CLOZAPINE; OLANZAPINE; PALIPERIDONE; QUETIAPINE; RISPERIDONE; ZIPRASIDONE;

ADULT; ARTICLE; BIPOLAR DISORDER; CARDIOVASCULAR RISK; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; ITALY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL DISEASE; MIDDLE AGED; OBESITY; PREVALENCE; PSYCHOSIS; AGED; CARDIOVASCULAR DISEASES; COMORBIDITY; MEDITERRANEAN DIET; MENTAL DISORDERS; RISK FACTOR;

ADULT; AGED; CARDIOVASCULAR DISEASES; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIET, MEDITERRANEAN; FEMALE; HUMANS; ITALY; MALE; MENTAL DISORDERS; MIDDLE AGED; PREVALENCE; RISK FACTORS;

EID: 84919449649     PISSN: 01638343     EISSN: 18737714     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2014.08.005     Document Type: Article

References (50)

1. Di Pasquale S., Pariante C.M., Dazzan P., Aguglia E., McGuire P., Mondelli V. The dietary pattern of patients with schizophrenia: a systematic review. J Psychiatr Res 2013, 47:197-207.
2. Mitchell A.J., Vancampfort D., Sweers K., et al. Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders - a systematic review and meta-analysis. Schizophr Bull 2013, 39:306-318.
3. Vancampfort D., Vansteelandt K., Correll C.U., Mitchell A.J., De Herdt A., Sienaert P., et al. Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderators. Am J Psychiatry 2013, 170:265-274.
4. Bartoli F., Carrà G., Crocamo C., Carretta D., Clerici M. Metabolic syndrome in people suffering from posttraumatic stress disorder: a systematic review and meta-analysis. Metab Syndr Relat Disord 2013, 11:301-308.
5. Bartoli F., Carrà G., Crocamo C., Carretta D., Clerici M. Bipolar disorder, schizophrenia, and metabolic syndrome. Am J Psychiatry 2013, 170:927-928.
6. De Hert M., Dekker J.M., Wood D., Kahl K.G., Holt R.I., Möller H.J. Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). Eur Psychiatry 2009, 24:412-424.
7. Osborn D.P., Wright C.A., Levy G., King M.B., Deo R., Nazareth I. Relative risk of diabetes, dyslipidaemia, hypertension and the metabolic syndrome in people with severe mental illnesses: systematic review and metaanalysis. BMC Psychiatry 2008, 8:84.
8. Filia S.L., Baker A.L., Gurvich C.T., Richmond R., Kulkarni J. The perceived risks and benefits of quitting in smokers diagnosed with severe mental illness participating in a smoking cessation intervention: gender differences and comparison to smokers without mental illness. Drug Alcohol Rev 2014, 33:78-85.
9. Van Winkel R., Van Os J., Celic I., Van Eyck D., Wampers M., Scheen A., et al. Psychiatric diagnosis as an independent risk factor for metabolic disturbances: results from a comprehensive, naturalistic screening program. J Clin Psychiatry 2008, 69:1319-1327.
10. Allison D.B., Newcomer J.W., Dunn A.L., Blumenthal J.A., Fabricatore A.N., Daumit G.L., et al. Obesity among those with mental disorders - A National Institute of Mental Health meeting report. Am J Prev Med 2009, 36:341-350.
11. Lawrence D., Hancock K.J., Kisely S. The gap in life expectancy from preventable physical illness in psychiatric patients in Western Australia: retrospective analysis of population based registers. BMJ 2013, 21(346):f2539. 10.1136/bmj.f2539.
12. Leucht S., Burkard T., Henderson J., Maj M., Sartorius N. Physical illness and schizophrenia: a review of the literature. Acta Psychiatr Scand 2007, 116:317-333.
13. Gough S.C.L., O'Donovan M.C. Clustering of metabolic comorbidity in schizophrenia: a genetic contribution?. J Psychopharmacol 2005, (19 Suppl.):47-55.
14. Hennekens C.H., Hennekens A.R., Hollar D., Casey D.E. Schizophrenia and increased risks of cardiovascular disease. Am Heart J 2005, 150:1115-1121.
15. Falissard B., Mauri M., Shaw K., Wetterling T., Doble A., Giudicelli A., et al. The METEOR study: frequency of metabolic disorders in patients with schizophrenia. Focus on first and second generation and level of risk of antipsychotic drugs. Int Clin Psychopharmacol 2011, 26:291-302.
16. Fernández-San-Martín M.I., Martín-López L.M., Masa-Font R., Olona-Tabueña N., Roman Y., Martin-Royo J., et al. The effectiveness of lifestyle interventions to reduce cardiovascular risk in patients with severe mental disorders: meta-analysis of intervention studies. Community Ment Health J 2014, 50:81-95.
17. Kokkinos P., Panagiotakos D.B., Polychronopoulos E. Dietary influences on blood pressure: the effect of the Mediterranean diet on the prevalence of hypertension. J Clin Hypertens (Greenwich) 2005, 7:165-170.
18. Chimonas T., Karagiannis A., Athyros V.G., Achimastos A., Elisaf M., Panagiotakos D.B., et al. Blood pressure levels constitute the most important determinant of the metabolic syndrome in a Mediterranean population: a discrimination analysis. Metab Syndr Relat Disord 2010, 8:523-529.
19. Salvi V., Albert U., Chiarle A., Soreca I., Bogetto F., Maina G. Metabolic syndrome in Italian patients with bipolar disorder. Gen Hosp Psychiatry 2008, 30:318-323.
20. Fusar-Poli P., De Marco L., Cavallin F., Bertorello A., Nicolasi M., Politi P. Lifestyles and cardiovascular risk in individuals with functional psychoses. Perspect Psychiatr Care 2009, 45:87-99.
21. Yazici M.K., Anil Yağcioğlu A.E., Ertuğrul A., Eni N., Karahan S., Karaağaoğlu E., et al. The prevalence and clinical correlates of metabolic syndrome in patients with schizophrenia: findings from a cohort in Turkey. Eur Arch Psychiatry Clin Neurosci 2011, 261:69-78.
22. Cicero A.F., Forghieri M., Cipressi F., Arletti R. Cardiovascular risk factors in severely ill psychiatric patients. Epidemiol Prev 2003, 27:40-43.
23. Istituto Nazionale di Statistica [ISTAT] Annuario statistico italiano 2011 Retrieved from. http://www3.istat.it/dati/catalogo/20111216_00/asi2011.zip.
24. World Medical Association WMA Declaration of Helsinki: ethical principles for medical research involving human subjects 2008, WMA, Ferney-Voltaire, France, [Retrieved from http://www.wma.net/en/30publications/10policies/b3/index.html].
25. Alcohol, Drug Abuse, and Mental Health Administration - ADAMHA. Reorganization Act 1992, 102-321. Pub. L. No.
26. Endicott J., Spitzer R.L., Fleiss J.L., Cohen J. The Global Assessment Scale: a procedure for measuring the overall severity of psychiatric disturbance. Arch Gen Psychiatry 1976, 33:766-771.
27. Carrà G., Sciarini P., Segagni-Lusignani G., Clerici M., Montomoli C., Kessler R.C. Do they actually work across borders? Evaluation of two measures of psychological distress as screening instruments in a non Anglo-Saxon country. Eur Psychiatry 2011, 26:122-127.
28. Spitzer R.L., Williams J.B., Gibbon M., First M.B. The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. Arch Gen Psychiatry 1992, 49:624-629.
29. National Cholesterol Education Program Third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002, 106:3143-3421.
30. Osborn D.P.J., Nazareth I., King M.B. Risk for coronary heart disease in people with severe mental illness: cross-sectional comparative study in primary care. Br J Psychiatry 2006, 188:271-277.
31. Centers for Disease Control, Prevention State-specific secondhand smoke exposure and current cigarette smoking among adults United States. MMWR Morb Mortal Wkly Rep 2009, 58:1232-1235.
32. Atkins M., Burgess A., Bottomley C., Riccio M. Chlorpromazine equivalents: a consensus of opinion for both clinical and research applications. Psychiatr Bull R Coll Psychiatr 1997, 21:224-226.
33. Lehman A.F., Steinwachs D.M. Translating research into practice: the Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations. Schizophr Bull 1998, 24:1-10.
34. Woods S.W. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 2003, 64:663-667.
35. Kroken R.A., Johnsen E., Ruud T., Wentzel-Larsen T., Jørgensen H.A. Treatment of schizophrenia with antipsychotics in Norwegian emergency wards, a cross-sectional national study. BMC Psychiatry 2009, 9:24.
36. Andreasen N.C., Pressler M., Nopoulos P., Miller D., Ho B.C. Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs. Biol Psychiatry 2010, 67:255-262.
37. World Health Organization [WHO] Waist circumference and waist-hip ratio: report of a WHO expert consultation. Geneva, 8-11 December 2008 2011, WHO, Geneva, Switzerland, [Retrieved from http://whqlibdoc.who.int/publications/2011/9789241501491_eng.pdf].
38. Carrà G., Bartoli F., Carretta D., Crocamo C., Bozzetti A., Clerici M., et al. The prevalence of metabolic syndrome in people with severe mental illness. Soc Psychiatry Psychiatr Epidemiol 2014, 10.1007/s00127-014-0835-y.
39. Keenan T.E., Yu A., Cooper L.A., Appel L.J., Guallar E., Gennusa J.V., et al. Racial patterns of cardiovascular disease risk factors in serious mental illness and the overall U.S. population. Schizophr Res 2013, 150:211-216.
40. Osborn D.P., Baio G., Walters K., Petersen I., Limburg H., Reine R., et al. Inequalities in the provision of cardiovascular screening to people with severe mental illnesses in primary care. Cohort study in the United Kingdom THIN Primary Care Database 2000-2007. Schizophr Res 2011, 129:104-110.
41. Chacón F., Mora F., Gervas-Rios A., Gilaberte I. Efficacy of lifestyle interventions in physical health management of patients with severe mental illness. Ann Gen Psychiatry 2011, 10:22.
42. Van Hasselt F.M., Krabbe P.F.M., van Ittersum D.G., Postma M.J., Loonen A.J.M. Evaluating interventions to improve somatic health in severe mental illness: a systematic review. Acta Psychiatr Scand 2013, 128:251-260.
43. Apolone G., Lattuada L. Health coverage in Italy. J Ambul Care Manage 2003, 26:378-382.
44. Birkenaes A.B., Opjordsmoen S., Brunborg C., Engh J.A., Jonsdottir H., Ringen P.A., et al. The level of cardiovascular risk factors in bipolar disorder equals that of schizophrenia: a comparative study. J Clin Psychiatry 2007, 68:917-923.
45. Gonçalves-Pereira M., Xavier M., van Wijngaarden B., Papoila A.L., Schene A.H., Caldas-de-Almeida J.M. Impact of psychosis on Portuguese caregivers: a cross-cultural exploration of burden, distress, positive aspects and clinical-functional correlates. Soc Psychiatry Psychiatr Epidemiol 2013, 48:325-335.
46. Bonaccio M., Iacoviello I., de Gaetano G. The Mediterranean diet: The reasons for a success. Thromb Res 2012, 129:401-404. Moli-Sani Investigators.
47. Sicras-Mainar A., Blanca-Tamayo M., Rejas-Gutiérrez J., Navarro-Artieda R. Metabolic syndrome in outpatients receiving antipsychotic therapy in routine clinical practice: a cross-sectional assessment of a primary health care database. Eur Psychiatry 2008, 23:100-108.
48. Meer J., DLc Miller, Rosen H.S. Exploring the health-wealth nexus. J Health Econ 2003, 22:713-730.
49. Carrà G., Johnson S. Variations in rates of comorbid substance use in psychosis between mental health settings and geographical areas in the UK. A systematic review. Soc Psychiatry Psychiatr Epidemiol 2009, 44:429-447.
50. Carrà G., Johnson S., Bebbington P., Angermeyer M.C., Heider D., Brugha T., et al. The lifetime and past-year prevalence of dual diagnosis in people with schizophrenia across Europe: findings from the European Schizophrenia Cohort (EuroSC). Eur Arch Psychiatry Clin Neurosci 2012, 262:607-616.